Author: admin

Content Delivery Network Market Growing Trends, Size, Share, Future Growth, Industry Analysis, Advance Technology And Forecast – 2028

“Akamai Technologies (US), Microsoft (US), IBM (US), Edgio (US), Google (US), AWS (US), AT&T (US), Cloudflare (US), Lumen Technologies (US), Deutsche Telekom (Germany), Fastly (US), Citrix systems (US), NTT Communications (Japan), Comcast Technologies (US).”
Content Delivery Network Market by Component (Solutions (Web Performance Optimization, Media Delivery, Cloud Security) and Services), Content Type (Static and Dynamic), Provider Type, Application Area and Region – Global Forecast to 2028.

The content delivery network (CDN) market is anticipated to expand from USD 21.7 billion in 2023 to USD 36.5 billion by 2028, achieving a CAGR of 10.9% during the forecast period. The growth is driven by the increasing demand for efficient solutions that ensure seamless and uninterrupted delivery of live content over high-speed data networks.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=657  

Based on application area, the Media delivery segment to hold the largest market size during the forecast period.

Media delivery involves the efficient distribution of rich media files like audio streaming, live videos, and video streaming. It focuses on reducing latency and ensuring a high-quality user experience, particularly for online media streaming. CDN companies offer solutions that enable faster and scalable delivery of HD videos, OTT content, games, social media platforms, and software updates. As the number of portable devices increases, CDN solutions help deliver digital content in various formats tailored to each device. Market players such as Akamai, AWS, Verizon, and Comcast offer media delivery solutions to meet the growing demand for seamless and engaging media experiences.

Based on provider type, P2P CDN is projected to register the highest CAGR during the forecast period.

P2P CDN solutions utilize ad-hoc connections to connect delivery nodes for digital content, offering diverse connectivity and consuming more bandwidth compared to traditional CDNs. Deployed at the client’s side, P2P CDNs leverage peer bandwidth, reducing network costs for content providers. The number of peers directly impacts network costs, making P2P CDN attractive for optimizing web performance. Factors such as the demand for 4K content, digitalization, and increasing internet penetration are driving the growth of the P2P CDN market segment, particularly with the growing popularity of video streaming.

Based on application area, the media and entertainment segment to hold the largest market size during the forecast period.

The media and entertainment industry relies heavily on CDN solutions to deliver users fast, secure, and uninterrupted viewing experiences. The increasing demand for online video streaming has driven the growth of this segment. CDN solutions optimize content delivery, reducing delays and enhancing device visual quality. By leveraging CDN technology, media and entertainment enterprises can cater to a global audience, offering seamless access to content regardless of location. Cloud-based services and CDN implementations support on-demand content, online audio streaming, podcasts, and live web episodes. The vast amount of data shared on social media platforms necessitates reliable CDN solutions for media production companies, animation studios, TV channels, and post-production teams. The evolution of higher-resolution imaging standards and the exponential growth in data sizes require robust CDN solutions. Key players in the CDN market for media and entertainment include Akamai, StackPath, and Limelight.

Based on region, Asia Pacific is projected to register the highest CAGR during the forecast period.

Asia Pacific, an emerging economy, is projected to achieve the highest CAGR in the CDN market during the forecast period. The region, including China, Japan, and South Korea, is experiencing significant growth driven by increasing content consumption, expanding internet subscriber base, and rising smartphone usage. The adoption of live video streaming, OTT services, and the surge in media, entertainment, gaming, and education sectors due to COVID-19 lockdowns further contribute to market growth. The booming eCommerce industry and the adoption of internet TV in countries like India, China, Korea, and Singapore also fuel the demand for CDN solutions. Major CDN vendors have established data centers in Asia Pacific to meet the growing demand and enhance customer experience while ensuring security compliance.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=657  

Unique Features in the Content Delivery Network Market

Modern CDNs integrate edge computing, enabling data processing closer to end users. This reduces latency and enhances real-time application performance, making it essential for IoT, online gaming, and live streaming.

CDNs are evolving beyond static content delivery to dynamically optimize and deliver personalized, real-time content, improving user experiences for applications such as e-commerce and media streaming.

To enhance reliability and minimize downtime, CDNs now support multi-CDN strategies, allowing businesses to leverage multiple networks for optimal performance and failover redundancy.

CDNs are equipped with robust security tools such as DDoS protection, web application firewalls (WAF), and bot mitigation to safeguard against cyberattacks and ensure secure content delivery.

Many CDN platforms offer real-time insights into traffic patterns, user behavior, and performance metrics, enabling businesses to make data-driven decisions and optimize content delivery strategies.

With a focus on high-quality video delivery, CDNs now support advanced streaming protocols, adaptive bitrate streaming, and low-latency features to cater to the growing demand for video-on-demand and live streaming services.

Major Highlights of the Content Delivery Network Market

The surge in demand for high-quality video content, including OTT platforms, live sports streaming, and video conferencing, is driving CDN adoption. Advanced video delivery capabilities, such as adaptive bitrate streaming, are key enablers of this trend.

The incorporation of edge computing into CDN solutions is a transformative development. By processing data closer to users, CDNs reduce latency and enable real-time applications, making them essential for industries like gaming and IoT.

With increasing cyber threats, CDNs now offer enhanced security features such as DDoS mitigation, bot protection, and web application firewalls (WAF). These features ensure secure content delivery and protect against disruptions.

CDNs are evolving to support emerging technologies like 5G, augmented reality (AR), and virtual reality (VR). This adaptability is positioning them as critical enablers of innovative applications in entertainment, healthcare, and education.

Businesses are increasingly employing multi-CDN strategies to enhance reliability, minimize downtime, and improve content delivery performance. This trend is driving the development of interoperable and flexible CDN solutions.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=657  

Top Companies in the Content Delivery Network Market

The major vendors covered in the content delivery network market include  Akamai Technologies (US), Microsoft (US), IBM (US), Edgio (US), Google (US), AWS (US), AT&T (US), Cloudflare (US), Lumen Technologies (US), Deutsche Telekom (Germany), Fastly (US), Citrix systems (US), NTT Communications (Japan), Comcast Technologies (US), Rackspace Technology (US), CDNetworks (South Korea), Tata Communications (India), Imperva (US), Broadpeak (France), Quantil (US), StackPath (US), G Core Labs SA (Luxembourg), Tencent Cloud (China), OnApp Limited (UK), EVG Corp (Vietnam), Kingsoft Cloud (China), Bunny.net (Slovenia) and Baishan Cloud (US). These players have adopted various growth strategies, such as partnerships, business expansions, agreements, collaborations, and new product launches, to expand their content delivery network market presence.

Akamai Technologies is a CDN provider that acts as an edge platform and uses the customers’ existing cloud service to deliver their content fast and securely. Akamai is a global and key player in the CDN market. It offers CDN solutions that help network administrators manage cost-efficient networks, develop new subscriber services, increase security, capitalize on growth in traffic, and reduce the complexity of managing a CDN network. Akamai offers various solutions, including security, web performance, media delivery, and network operator solutions. Akamai helps telecommunication providers deliver broadcast-quality experiences and high-quality video to their subscribers without building the CDN infrastructure with its network operator solution. The company offers its media delivery solution and other cloud services, which enterprises use to deliver content to their stakeholders.

Microsoft is a software corporation that develops, manufactures, licenses, supports, and sells software products and services. The company provides solutions in applications and infrastructure, data and AI, developer tools, power platform, business applications, security, and more. Microsoft Azure CDN enables users to reduce load times, save bandwidth, and speed responsiveness while performing actions such as developing websites or mobile apps, distributing streaming media, gaming software, firmware updates or IoT endpoints. The solution has a distributed and global presence and thus can easily handle sudden traffic spikes and heavy loads. Moreover, the CDN works seamlessly with Azure services, including web apps, media services, storage, and cloud services. It enables users to gain insights about customer workflows and business needs by tracking engagement with the content.

IBM (International Business Machines Corporation): IBM is a multinational technology and consulting company headquartered in Armonk, New York. Founded in 1911, IBM is a pioneer in the technology industry, known for its contributions to computer hardware, software, and IT services. The company has been instrumental in the development of mainframe computers and is a leader in emerging technologies such as artificial intelligence (AI), cloud computing, quantum computing, and blockchain. IBM also provides extensive consulting services, helping businesses leverage technology to drive innovation and efficiency across various sectors.

Edgio: Edgio, formerly known as Limelight Networks, is a U.S.-based company specializing in content delivery network (CDN) services, edge computing, and cloud security. Headquartered in Scottsdale, Arizona, Edgio helps businesses deliver high-performance digital experiences by providing solutions for video streaming, website acceleration, and online security. The company’s edge platform enhances the speed, reliability, and security of digital content delivery, making it a valuable partner for organizations looking to optimize their online presence and user experience.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Content Delivery Network Market Growing Trends, Size, Share, Future Growth, Industry Analysis, Advance Technology And Forecast – 2028

Hepatocellular Carcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

“Hepatocellular Carcinoma Clinical Trials”
Hepatocellular Carcinoma companies are Can-Fite BioPharma, Sinocelltech, AVEO Oncology, Oxford BioTherapeutics, Beijing SyngenTech, Surface Oncology, Novartis Oncology, Array BioPharma, Taizhou Hanzhong Pharmaceuticals, Akeso Biopharma, Shanghai Henlius Biotech, Chugai Pharmaceutical, CStone Pharmaceuticals, Shenogen Pharma, GlaxoSmithKline, Tarus Therapeutics, Tvardi Therapeutics, Virogin Biotech, Yiviva, Chia Tai Tianqing Pharmaceutical Group, Antengene Corporation, Iterion Therapeutics, more

(Albany, USA) As per DelveInsight’s assessment, globally, about 90+ key pharma and biotech companies are working on 95+ pipeline drugs in the Hepatocellular Carcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

“Hepatocellular Carcinoma Pipeline Insight 2024” report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Hepatocellular Carcinoma Therapeutics Market. The report provides a detailed description of the Hepatocellular Carcinoma drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

 

Get a Detailed Overview of the Hepatocellular Carcinoma Clinical Trial Activities and Regulatory Developments in the domain @ Hepatocellular Carcinoma Pipeline Analysis

 

Some facts of the Hepatocellular Carcinoma Pipeline are:

  • Hepatocellular Carcinoma Companies across the globe are diligently working toward developing novel Hepatocellular Carcinoma treatment therapies with a considerable amount of success over the years.
  • Hepatocellular Carcinoma companies working in the treatment market are Can-Fite BioPharma, Sinocelltech, AVEO Oncology, Oxford BioTherapeutics, Beijing SyngenTech, Surface Oncology, Novartis Oncology, Array BioPharma, Taizhou Hanzhong Pharmaceuticals, Akeso Biopharma, Shanghai Henlius Biotech, Chugai Pharmaceutical, CStone Pharmaceuticals, Shenogen Pharma, GlaxoSmithKline, Tarus Therapeutics, Tvardi Therapeutics, Virogin Biotech, Yiviva, Chia Tai Tianqing Pharmaceutical Group, Antengene Corporation, Iterion Therapeutics, Sumitomo Pharma, SillaJen Biotherapeutics, SCG Cell Therapy, Guangdong ProCap Zoom Biosciences, Eutilex, Polaris Pharmaceuticals, OriCell Therapeutics, and others, are developing therapies for the Hepatocellular Carcinoma treatment
  • Emerging Hepatocellular Carcinoma therapies in the different phases of clinical trials are Namodenoson, SRF388, Porustobart, Fisogatinib, STP705, and others are expected to have a significant impact on the Hepatocellular Carcinoma market in the coming years.
  • In September 2024:- Translational Research in Oncology- A Phase III, Multicenter, Randomized, Open-label Trial to Evaluate the Safety and Efficacy of Systemic Therapy With Regorafenib and Pembrolizumab Versus Locoregional Therapy With Transarterial Chemoembolization or Transarterial Radioembolization, for the First-line Treatment of Intermediate-stage Hepatocellular Carcinoma With Beyond Up-to-7 Criteria
  • In September 2024:- Hoffmann-La Roche- This is a Phase Ib/II, open-label, multicenter, randomized platform study to evaluate neoadjuvant immunotherapy combinations in participants with resectable HCC. The study is designed with the flexibility to open new treatment arms as new agents become available, close existing treatment arms that demonstrate minimal clinical activity or unacceptable toxicity, or modify the participant population.
  • In September 2024:- Akeso- The goal of phase Ib trial is to evaluate the safety and tolerability of AK112 in combination therapies for the purpose of observing the incidence of dose limit toxicity (DLT) as well as the confirmation of maximum tolerable dose (MTD) in the treatment of advanced hepatocellular carcinoma (HCC), so as to determine the recommended phase 2 dose (RP2D) in the second part of the trial.

 

Hepatocellular Carcinoma (HCC) Pipeline Analysis

The report provides insights into:

  • The report provides detailed insights into the key companies that are developing Hepatocellular Carcinoma therapies.
  • The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hepatocellular Carcinoma treatment.
  • It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • It navigates the emerging Hepatocellular Carcinoma drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Hepatocellular Carcinoma treatment market.

 

Learn More about the Clinical and Commercial Development Activities in the Hepatocellular Carcinoma Therapeutics Domain @ Hepatocellular Carcinoma FDA Approvals and Advancements

 

Hepatocellular Carcinoma (HCC) Therapeutics Analysis

About 90+ notable companies are actively involved in developing therapies for Hepatocellular Carcinoma (HCC). Among them, Can-Fite BioPharma stands out as a key player, advancing its HCC drug candidates to the most advanced stage, Phase III.

 

Hepatocellular Carcinoma Companies in the Therapeutics Market Include:

Can-Fite BioPharma, Sinocelltech, AVEO Oncology, Oxford BioTherapeutics, Beijing SyngenTech, Surface Oncology, Novartis Oncology, Array BioPharma, Taizhou Hanzhong Pharmaceuticals, Akeso Biopharma, Shanghai Henlius Biotech, Chugai Pharmaceutical, CStone Pharmaceuticals, Shenogen Pharma, GlaxoSmithKline, Tarus Therapeutics, Tvardi Therapeutics, Virogin Biotech, Yiviva, Chia Tai Tianqing Pharmaceutical Group, Antengene Corporation, Iterion Therapeutics, Sumitomo Pharma, SillaJen Biotherapeutics, SCG Cell Therapy, Guangdong ProCap Zoom Biosciences, Eutilex, Polaris Pharmaceuticals, and OriCell Therapeutics are the leading pharma giants shaping the landscape of the Hepatocellular Carcinoma Therapeutic Market.

 

Emerging and Marketed Hepatocellular Carcinoma Therapies Covered in the Report Include:

  • Namodenoson: Can-Fite BioPharma
  • SRF388: Surface Oncology
  • Porustobart: Harbour BioMed
  • Fisogatinib: CStone Pharmaceuticals
  • STP705: Sirnaomics
  • And Many Others

 

Get an in-depth Assessment of the Emerging Therapies and Hepatocellular Carcinoma Companies Actively Working in the Market @ Hepatocellular Carcinoma Drugs in Pipeline

 

Hepatocellular Carcinoma Drugs Uptake

The Report Covers the Emerging Hepatocellular Carcinoma Therapies Under Different Phases of Clinical Development Like –

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I)
  • Pre-clinical and Discovery stage candidates
  • Discontinued and inactive candidates

 

Route of Administration

Hepatocellular Carcinoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

 

Molecule Type

Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy

 

Request for Sample PDF to Understand More About the Hepatocellular Carcinoma Treatment Outlook and Future Perspectives @ Hepatocellular Carcinoma Drugs and Therapies

 

Table of Content

1. Report Introduction

2. Executive Summary

3. Hepatocellular Carcinoma Current Treatment Patterns

4. Hepatocellular Carcinoma – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Hepatocellular Carcinoma Late-Stage Products (Phase-III)

7. Hepatocellular Carcinoma Mid-Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Hepatocellular Carcinoma Discontinued Products

13. Hepatocellular Carcinoma Product Profiles

14. Hepatocellular Carcinoma Companies

15. Hepatocellular Carcinoma Drugs

16. Dormant and Discontinued Products

17. Hepatocellular Carcinoma Unmet Needs

18. Hepatocellular Carcinoma Future Perspectives

19. Hepatocellular Carcinoma Analyst Review

20. Appendix

21. Report Methodology

 

Latest Report:

Urolithiasis market

DelveInsight’s “Urolithiasis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Urolithiasis, historical and forecasted epidemiology as well as the Urolithiasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hepatocellular Carcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

Long Term Care at Home Pharmacy Quality Commission Sets New Standards for Industry Excellence

The Long Term Care at Home Pharmacy Quality Commission (LTC@HQC) has set new standards for home-based pharmacy care, ensuring quality and safety for vulnerable patients.

Philadelphia, PA – December 18th, 2024 – The Long Term Care at Home Pharmacy Quality Commission (LTC@HQC) today announced the release of the first-ever industry standards specifically designed for pharmacies engaged in Long Term Care Pharmacy at Home. This landmark achievement establishes a new benchmark for pharmacy care delivery, prioritizing quality service and patient well-being for chronically ill and aging individuals receiving care in their homes.

“As we unveil these official standards,” said Lindsay Dymowski Constantino, president of LTC@HQC, “we are setting a new benchmark in pharmacy care that promises not only to elevate service quality but also to instill greater trust in the sector. These standards are more than guidelines; they are a commitment to our most vulnerable populations that their care is paramount.”

Key Points:

  • Industry-First Standards: Following over two years of research and collaboration with hundreds of long term care pharmacies, the LTC@HQC has officially published comprehensive standards for the sector.

  • Enhanced Quality and Compliance: These standards meticulously integrate historical Centers for Medicare & Medicaid Services (CMS) requirements with unique processes tailored to the Long Term Care Pharmacy at Home environment. They also provide standardized compliance documentation and templated forms to ensure industry-wide consistency.

  • Accreditation Program Launched: Building upon the established standards, the LTC@HQC launched its first-ever accreditation program in October 2024. This program empowers pharmacies to demonstrate their commitment to excellence and patient safety by ensuring adherence to healthcare regulations and consistent service delivery.

Moving the Industry Forward

The release of these standards and the launch of the accreditation program represent a significant milestone in professionalizing and standardizing Long Term Care Pharmacy at Home services. This initiative aligns with broader healthcare goals of ensuring quality and safety while addressing the specific needs of individuals receiving care at home.

Invitation to Collaborate

The LTC@HQC welcomes stakeholders across the healthcare ecosystem to join this critical endeavor. Payers, health plans interested in implementing these standards, and organizations seeking to become verified accreditation bodies for LTC@HQC can find more information at ltcathomequalitycommission.com or contact support@ltcathomequalitycommission.com

About the Long Term Care at Home Pharmacy Quality Commission

The Long Term Care at Home Pharmacy Quality Commission (LTC@HQC) is dedicated to advancing the highest standards of pharmacy care for patients receiving long-term care pharmacy at home. Through certification, accreditation, education, and collaboration, the LTC@HQC strives to ensure every patient receives compliant, safe, and compassionate pharmacy care tailored to their individual needs.

Lindsay Dymowski

Lindsay Dymowski Constantino is a recognized leader in the Long Term Care Pharmacy at Home sector, serving as the President of the Long Term Care at Home Pharmacy Quality Commission. With over 15 years of industry experience, her expertise in medication management for home-based care has established new benchmarks for patient-centric pharmacy services. Lindsay’s visionary leadership has been pivotal in fostering collaborations between pharmacies, healthcare providers, and payers, focusing on enhancing health outcomes through integrated and personalized pharmacy care in the patient’s home. Her strategic approach emphasizes comprehensive support and better health outcomes.

Passionate about the business of pharmacy and its future in healthcare, Lindsay has presented at national conferences, received media coverage throughout various outlets, designed continuing education curriculum, and currently sits on several boards committed to the advancement of the practice of pharmacy. Lindsay has been featured in Mcknights and MPR among other publications.

For media inquiries or to request an interview, please contact:

Dave Purdy

david.purdy@otterpr.com

Media Contact
Company Name: OtterPR
Contact Person: Dave Purdy
Email: Send Email
Phone: 7274002578
Address:136 4th St N Ste 201
City: SAINT PETERSBURG
State: Florida
Country: United States
Website: https://otterpr.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Long Term Care at Home Pharmacy Quality Commission Sets New Standards for Industry Excellence

Pocket FM Collaborates with Bollywood Music Icon Sneha Khanwalkar to Create World’s First Crowdsourced Sonic Tune

Sneha Khanwalkar, via her platform SoundCake, to Unite Creators and Listeners in Crafting Pocket FM’s Iconic Sonic Tune

Los Angeles, CA – December 18, 2024 – Imagine if the tune of your favorite brand was created by you! Audio series platform Pocket FM is making this a reality. In a first-of-its-kind initiative, it is collaborating with renowned Bollywood music director Sneha Khanwalkar and her platform SoundCake—a global community of 15,000+ creators including musicians, singers, and lyricists—to crowdsource its sonic tune, making it the world’s first sonic identity shaped collectively by creators and listeners.

This global campaign promises to amplify creativity and community participation, making it a one-of-a-kind endeavor in the branding space. With the SoundCake community of over 8,000 singers, 5,000 musicians, and 1,400 sound artists,  Pocket FM is inviting creative enthusiasts worldwide to submit their original compositions and become part of this innovative endeavor.

“At Pocket FM, our community lies at the core of everything we create,” said Vineet Singh, VP – Brand and Communications, Pocket FM. “By crowdsourcing our sonic tune, we are empowering our creators and listeners to actively shape our sonic identity. Partnering with SoundCake and the incredible Sneha Khanwalkar combines expertise with passion, resulting in something truly unique. This initiative is more than a branding exercise; it’s a movement celebrating creativity, collaboration, and shared ownership.”

How It Works

The campaign brings creators and listeners together in a highly engaging process. Creators from the SoundCake community and also Pocket FM listeners community will get the opportunity to submit their compositions, from which Sneha Khanwalkar will personally curate the top three entries. These shortlisted tunes will then be shared with Pocket FM’s 200 million+ listeners worldwide, who, along with Pocket FM employees, will cast their votes through social media and the Pocket FM app to select the final tune.

The winning tune will be professionally produced by Khanwalkar in collaboration with the selected creator, marking a revolutionary approach to sonic branding that is deeply personal, authentic, and community-driven.

“Music is universal! It connects people, brings them together,” said Sneha Khanwalkar, Founder of SoundCake. “With Pocket FM and SoundCake, we’re taking this connection to a whole new level by co-creating a sound that reflects the audience it’s meant for. The immense talent within the SoundCake community, paired with Pocket FM’s listener-first approach, makes this a truly exciting project. Together, we’re setting a new standard for what sonic branding can achieve.”

Celebrating Sonic Innovation and Crowdsourcing

Sonic branding has become an essential tool for brands today, offering a unique way to stand out in crowded markets. By incorporating the voices and creativity of its community, Pocket FM is pioneering a collaborative approach to create a sonic tune that not only reinforces its brand identity but also resonates deeply with its audience.

This initiative also showcases SoundCake’s vibrant community of creators and Pocket FM’s commitment to celebrating the power of crowdsourcing. By bringing creators and listeners together, the platform is breaking traditional boundaries in branding, transforming its sonic tune into a shared celebration of creativity and community spirit.

Sneha Khanwalkar’s renowned modern sound design, celebrated in iconic soundtracks like Gangs of Wasseypur and Oye Lucky! Lucky Oye!, combined with her recent global success on Monkey Man with Dev Patel, makes her the perfect collaborator for this visionary campaign. Her experimental approach to music ensures the resulting tune will be both groundbreaking and emotionally resonant.

By weaving crowdsourcing and sonic innovation into its DNA, Pocket FM is not just crafting a sonic tune—it’s creating an anthem of collaboration that will echo for years to come.

About Pocket FM: 

Pocket FM is the world’s largest audio series platform, with a global community of over 200 million listeners. The company has redefined audio storytelling by pioneering the audio series category and bringing it into mainstream entertainment with its episodic storytelling format. This innovative approach has fostered binge-listening behavior, with the platform seeing an average of over 115 minutes of daily listener time. Pocket FM offers more than 75,000 audio series, powered by a community of 250,000+ writers worldwide.

Available on iOS and Android, click here to download Pocket FM. For more information, please get in touch with communications@pocketfm.com

About SoundCake:

SoundCake is a platform that links talent to the creative industry, offering a wealth of opportunities in the professional landscape. This initiative is a major move toward fostering seamless collaboration and cultivating a global community of musicians, designers, and artists. Presently, SoundCake boasts a community of over 15,000 creative professionals, which includes more than 8,000 singers, over 5,000 musicians, around 1,400 sound artists, and approximately 1,200 designers.

Visit https://www.soundcake.io/about_us for more information.

Media Contact
Company Name: Pocket FM
Email: Send Email
Country: United States
Website: https://pocketfm.com/us

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pocket FM Collaborates with Bollywood Music Icon Sneha Khanwalkar to Create World’s First Crowdsourced Sonic Tune

Don’t Miss The Last Call for the St. Pete’s Chanukah Party of the Year

Where Tradition Meets Trendy Come Celebrate Chanukah with Friends, Fun, and Festivities at FLAME

St. Petersburg, Florida – Whether you’re here for the latkes, the laughs, or the connections, FLAME is the place to be this Chanukah season! St. Pete’s favorite Chanukah bash hosted by the Chabad Jewish Center of St. Petersburg for Jewish young professionals – is just around the corner. Mark your calendar for Saturday, December 28th at 8:00 PM at the trendy Savant on Second in Downtown St. Pete.

If you thought last year was fun, just wait – this year, things are turning up a notch! Start the night with a Grand Menorah Lighting, enjoy crispy latkes at the Fresh Latke Station, and show off your spinning skills in the Epic Dreidel Tournament. Don’t forget to rock your most outrageous outfit for the Ugly Chanukah Sweater Contest, and enjoy drinks from the Open Bar as you celebrate with friends!

Rabbi Menachem Mendel Lebovics, who hosts FLAME, couldn’t be more excited, “This night is all about celebrating Chanukah with friends, meeting new people, and just having a blast. If you’re a Jewish young professional, you don’t want to miss it – we’ve got all the ingredients for an amazing night!”

Secure your spot by purchasing your tickets HERE. Tickets are $36 if you purchase them by December 24th, or $50 at the door if you’re a last-minute planner. But don’t wait too long to join the biggest Chanukah celebration for young Jewish professionals in St. Pete!

About FLAME

FLAME is proudly brought to you by the Chabad Jewish Center of St. Petersburg, with the generous support of Jac Smith Group with Keller Williams Realty St. Pete and Otter PR. Whether you’re here to meet new friends, enjoy holiday traditions, or just have an incredible time, FLAME has something for everyone.

About Chabad

Chabad is a place where Jews of all backgrounds and observance levels come together to connect without judgment, FLAME is a part of the Chabad young professionals Community in St. Petersburg. 

Don’t Miss Out! Grab your ticket, pull out your craziest sweater, and come ready to celebrate the Festival of Lights like never before. It’s going to be a night to remember. For tickets and more details, head over to the Chabad Young Professionals website. 

Media Contact
Company Name: Chabad Jewish Center
Contact Person: Gaby Bernadet
Email: Send Email
Country: United States
Website: https://www.chabadsp.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Don’t Miss The Last Call for the St. Pete’s Chanukah Party of the Year

Connected Toys Market Emerging Technologies, Size, Share, Growth, Top Vendors, Future Opportunities, and Forecast 2028

“Mattel (US), The key market players profiled in the connected toys market report include Mattel (US), Hasbro (US), LEGO (Denmark), Sony (Japan), VTech (Hong Kong), UBTECH (China), DJI (China), iRobot (US), Sphero (US), Digital Dream Labs (US), Pillar Learning (US), Wonder Workshop (US), TOSY Robotics (Vietnam), Workinman Interactive (New York).”
Connected Toys Market by Application (Education, Entertainment), Age Group (1 -5 Years, 6 -8 Years, 9-12 Years, 13-19 Years), Interfacing Device (Smartphone/Tablet and PC/Laptop), Distribution Channel, Technology and Region – Global Forecast to 2028.

The connected toys market is expected to grow from USD 9.3 billion in 2023 to USD 24.1 billion by 2028, registering a CAGR of 20.7% during the forecast period. The rising number of households with both parents working has driven demand for connected toys equipped with monitoring and tracking features. This change in family dynamics has played a key role in the increasing popularity and adoption of connected toys.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38031230  

By age group, the 9-12 years segment has the highest growth rate during the forecast period.

The adoption of connected toys among teenagers is driven by factors such as their familiarity and comfort with technology as digital natives, and Teenagers are part of the digital-native generation, highly familiar with and comfortable using technology. Connected toys align with their tech-savvy lifestyles, offering a bridge between the physical and digital worlds.  It also offers educational content or opportunities for skill development, which can be attractive to teenagers seeking to learn and improve in a specific area. They interact with the screen as they play and learn.

By interfacing devices, the smartphone/tablet segment holds the highest market share during the forecast period.

The widespread ownership of smartphones and tablets has created a large and diverse user base, making these devices a convenient and accessible platform for connected toy manufacturers. The ubiquity of smartphones and tablets ensures that connected toys can easily reach a broad audience of consumers, including children, parents, and tech-savvy individuals.

North America has the highest market share during the forecast period.

The tech-savvy population in North America, characterized by a strong affinity for digital devices and experiences, is a key driver for the connected toys market. Connected toys cater to this digital lifestyle, offering interactive and engaging play options that resonate with children and teenagers in the region. Also, the region’s expertise in advanced technologies contributes to developing cutting-edge, connected toys, keeping North American consumers at the forefront of interactive play experiences.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38031230  

Unique Features in the Connected Toys Market

Connected toys incorporate advanced technologies such as artificial intelligence (AI) and machine learning (ML) to provide interactive and engaging play experiences. These toys can adapt to user preferences, respond to voice commands, and even simulate human-like interactions, enhancing entertainment and learning.

Many connected toys are designed to promote learning and skill development in children. Features like coding tutorials, STEM-based activities, and problem-solving games help foster cognitive and creative abilities while making learning fun and interactive.

Connected toys often come with integrated monitoring features, enabling parents to track their children’s activities through mobile apps. These features provide real-time updates, location tracking, and activity monitoring, ensuring both safety and peace of mind.

Modern connected toys can integrate seamlessly with smart home devices such as voice assistants (e.g., Alexa, Google Assistant). This connectivity allows for enhanced functionality, such as controlling toys via voice commands or integrating them into family routines.

With growing concerns about data security, connected toys now feature advanced encryption, parental control settings, and compliance with privacy regulations like GDPR and COPPA. These measures ensure a safer and more secure user experience.

Major Highlights of the Connected Toys Market

The rising popularity of smart and interactive toys, driven by advancements in AI and IoT technologies, is transforming the traditional toy industry. These toys provide immersive experiences, combining entertainment with learning.

The growing prevalence of households with two working parents has increased the demand for connected toys equipped with monitoring, tracking, and interactive capabilities. These features offer parents a way to stay engaged with their children’s activities, even from a distance.

Connected toys are becoming essential tools for early education and skill development. They offer STEM-focused activities, coding tutorials, and problem-solving challenges, aligning with the increasing emphasis on educational play.

The ability of connected toys to integrate with smart home systems and voice assistants, such as Alexa and Google Assistant, enhances their appeal. This integration allows for innovative functionalities, including voice-controlled games and interactive storytelling.

With rising concerns about cybersecurity, connected toy manufacturers are incorporating advanced safety measures, including encrypted data transmission, secure user authentication, and compliance with child safety regulations like COPPA.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=38031230  

Top Companies in the Connected Toys Market

The major players in the Connected Toys market are Mattel (US), The key market players profiled in the connected toys market report include Mattel (US), Hasbro (US), LEGO (Denmark), Sony (Japan), VTech (Hong Kong), UBTECH (China), DJI (China), iRobot (US), Sphero (US), Digital Dream Labs (US), Pillar Learning (US), Wonder Workshop (US), TOSY Robotics (Vietnam), Workinman Interactive (New York), WowWee Group (Hong Kong), KEYi Technology (China), Miko (India), Makeblock (China), Smart Teddy (US), Intelino (US), Fischertechnik (Germany), Potensic (China), Mainbot (France), ROYBI (US), PlayShifu (India). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches and product enhancements, and acquisitions, to expand their footprint in the Connected Toys market.

Mattel (US)

Mattel is a major toy firm that designs, manufactures, and markets toys worldwide. The company aims to create innovative products and experiences that inspire, entertain, and develop children through play. It engages customers through its portfolio of iconic franchises, which include Barbie Signature, Hot Wheels Collectors, WWE, Jurassic World, Karma’s World, Fisher-Price, American Girl, UNO, Little People, Star Wars, and more. Mattel also offers film and television content, operates across 40 locations, and delivers its products in more than 150 countries in collaboration with the world’s leading retail and technology companies, such as Walmart, Target, and Amazon.

Hasbro (US)

Hasbro is a global play and entertainment company committed to creating the world’s best play experiences. The company uses its brand blueprint to focus on reinforcing storylines associated with several outlets, including television, motion pictures, and digital brands. It offers a variety of ways for audiences to experience its iconic brands, including NERF, My Little Pony, Transformers, Play-Doh, Monopoly, and Baby Alive, as well as premier partner brands. The company’s Hasbro Studios and Allspark Pictures, its film label, create entertainment brand-driven storytelling across various mediums, including televisions and films. Hasbro continues to focus on innovation and developing its world-class brand portfolio. Hasbro Studios continues to drive entertainment, and brand-driven storytelling for Hasbro across televisions, films, commercial productions, and short-form content. It develops, produces, and distributes TV shows to leading networks in more than 35 countries, globally.

LEGO (Denmark)

LEGO, headquartered in Billund, Denmark, is renowned globally for its iconic plastic construction toys. Founded in 1932, LEGO has expanded from simple building blocks to intricate sets catering to various themes and age groups. The company emphasizes creativity, imagination, and learning through play, with products that include LEGO bricks, sets based on popular franchises like Star Wars and Marvel, and educational products like LEGO Education. LEGO has also ventured into digital games, movies, and theme parks, maintaining its commitment to quality, innovation, and sustainability in toy manufacturing.

Sony (Japan)

Sony Corporation, based in Tokyo, Japan, is a multinational conglomerate known for its extensive range of consumer electronics, gaming, entertainment, and financial services. Founded in 1946, Sony has grown into one of the world’s largest technology companies, with products including PlayStation gaming consoles, BRAVIA TVs, Xperia smartphones, cameras, audio equipment, and professional solutions. Sony is also a major player in the entertainment industry with Sony Pictures and Sony Music, producing films, TV shows, and music albums. The company is known for innovation, quality, and pushing the boundaries of technology in entertainment and electronics.

VTech (Hong Kong)

VTech Holdings Limited, headquartered in Hong Kong, is a global supplier of electronic learning products and telecommunication devices. Established in 1976, VTech specializes in educational toys, interactive electronic toys, cordless phones, and other telecommunications products. The company’s offerings include the VTech and LeapFrog brands, which focus on early childhood education through engaging and interactive technologies. VTech is committed to innovation in learning toys and communication solutions, serving families, schools, and businesses worldwide with products that promote learning, creativity, and communication skills in children and adults alike.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/connected-toys-market-38031230.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Connected Toys Market Emerging Technologies, Size, Share, Growth, Top Vendors, Future Opportunities, and Forecast 2028

Interstitial Lung Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

“Interstitial Lung Disease Clinical Trials”
Interstitial Lung Disease companies are AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, Genentech, Boehringer Ingelheim, Prometheus Biosciences, HEC Pharm, Bayer, Insmed, Bristol-Myers Squibb, Avalyn Pharma, PureTech Health, Roche, Ark Biosciences, Novartis, Kadmon Pharmaceuticals, GenKyoTex, Taiho Pharmaceutical,Syndax Pharmaceuticals, CSL Behring and AstraZeneca, and others.

(Albany, United States) As per DelveInsight’s assessment, globally, Interstitial Lung Disease pipeline constitutes 120+ key companies continuously working towards developing 120+ Interstitial Lung Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Interstitial Lung Disease Pipeline Insight, 2024″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Interstitial Lung Disease Market.

The Interstitial Lung Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

Request for Sample Report here @ Interstitial Lung Disease Pipeline Analysis 

 

Some of the key takeaways from the Interstitial Lung Disease Pipeline Report:

  • Interstitial Lung Disease Companies across the globe are diligently working toward developing novel Interstitial Lung Disease treatment therapies with a considerable amount of success over the years. 
  • Interstitial Lung Disease companies working in the treatment market are AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, Bellerophon Pulse Technologies, OncoArendi Therapeutics, LTT Bio-Pharma, EmphyCorp, Genentech, Cudetaxestat, Boehringer Ingelheim, Prometheus Biosciences, HEC Pharm, Bayer, Insmed, Bristol-Myers Squibb, Avalyn Pharma, PureTech Health, Roche, Ark Biosciences, Novartis, Lung Therapeutics, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics,  Kadmon Pharmaceuticals, GenKyoTex, Taiho Pharmaceutical,Syndax Pharmaceuticals, Metagone Biotech, Galecto Biotech, CSL Behring and AstraZeneca, and others are developing therapies for the Interstitial Lung Disease treatment.
  • Emerging Interstitial Lung Disease therapies such as AD-214, Abatacept, ATYR1923, Pirfenidone inhalation, RO-0220912, Lung stem cells, Bardoxolone methyl, Pamrevlumab, Deupirfenidone, INOpulse, OATD 01, LT 0011, GDC 3280,  Blade Therapeutics, BI 1015550, PRA 023, Yifenidone, Riociguat, Treprostinil Palmitil, BMS 986278, Pirfenidone inhalation,  Deupirfenidone, Zinpentraxin alfa, AK 3280, Ianalumab, LTI-03, HZN-825, Tipelukast, ENV-101, PLN-74809, KD025, Setanaxib, TAS-115,Axatilimab, MG-S-2525, GB0139,CSL312 and Saracatinib, others are expected to have a significant impact on the Interstitial Lung Disease market in the coming years.  
  • On March 2024, Boehringer Ingelheim announced a Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
  • On April 2024, Boehringer Ingelheim announced a Prospective, Observational Study on the Correlations Between Change in Lung Function and Change in Cough and Dyspnoea in Patients With Connective Tissue Disease-associated Progressive Fibrosing INTErstitial luNg diseaSE (CTD Associated PF-ILD) Treated With Nintedanib. The “INTENSE” Study.
  • On January 2024, aTyr Pharma, Inc. announced a Randomized, Double-blind, Placebo-controlled Proof-of-Concept (PoC) Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD).

 

Interstitial Lung Disease Overview

Interstitial lung disease (ILD) encompasses a diverse group of disorders characterized by inflammation and scarring of lung tissue, leading to impaired gas exchange. Common symptoms include progressive dyspnea (shortness of breath), cough, and fatigue. ILD can be caused by various factors, including environmental exposures (such as asbestos or silica dust), autoimmune diseases (like rheumatoid arthritis or scleroderma), medications, and genetic predispositions. Diagnosis often involves a combination of clinical evaluation, imaging studies (such as high-resolution CT scans), pulmonary function tests, and sometimes lung biopsies. Treatment aims to alleviate symptoms, slow disease progression, and improve quality of life, and may include medications like corticosteroids, immunosuppressants, or antifibrotic agents. In some cases, lung transplantation may be considered for advanced disease. Prognosis varies depending on the specific type and severity of ILD, with some forms having a better outlook than others. Early detection and management are crucial in optimizing outcomes for patients with ILD.

 

Get a Free Sample PDF Report to know more about Interstitial Lung Disease Pipeline Therapeutic Assessment- Interstitial Lung Disease Treatment Market

 

Interstitial Lung Disease Route of Administration

Interstitial Lung Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

  • Oral
  • Intravenous
  • Subcutaneous

 

Interstitial Lung Disease Molecule Type

Interstitial Lung Disease Products have been categorized under various Molecule types, such as

  • Small molecule
  • Cell Therapy
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy 

 

Interstitial Lung Disease Pipeline Therapeutics Assessment

  • Interstitial Lung Disease Assessment by Product Type
  • Interstitial Lung Disease By Stage and Product Type
  • Interstitial Lung Disease Assessment by Route of Administration
  • Interstitial Lung Disease By Stage and Route of Administration
  • Interstitial Lung Disease Assessment by Molecule Type
  • Interstitial Lung Disease by Stage and Molecule Type

 

DelveInsight’s Interstitial Lung Disease Report covers around 120+ products under different phases of clinical development like-

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I)
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Further Interstitial Lung Disease product details are provided in the report. Download the Interstitial Lung Disease pipeline report to learn more about the emerging Interstitial Lung Disease therapies- Interstitial Lung Disease Drugs and Therapies

 

Interstitial Lung Disease Pipeline Analysis:

The Interstitial Lung Disease pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Interstitial Lung Disease with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Interstitial Lung Disease Treatment.
  • Interstitial Lung Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Interstitial Lung Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Interstitial Lung Disease market.

 

Download Sample PDF Report to know more about Interstitial Lung Disease drugs and therapies- Interstitial Lung Disease Therapeutics Market

  

Scope of Interstitial Lung Disease Pipeline Drug Insight    

  • Coverage: Global
  • Key Interstitial Lung Disease Companies: AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, Bellerophon Pulse Technologies, OncoArendi Therapeutics, LTT Bio-Pharma, EmphyCorp, Genentech, Cudetaxestat, Boehringer Ingelheim, Prometheus Biosciences, HEC Pharm, Bayer, Insmed, Bristol-Myers Squibb, Avalyn Pharma, PureTech Health, Roche, Ark Biosciences, Novartis, Lung Therapeutics, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics,  Kadmon Pharmaceuticals, GenKyoTex, Taiho Pharmaceutical,Syndax Pharmaceuticals, Metagone Biotech, Galecto Biotech, CSL Behring and AstraZeneca, and others.
  • Key Interstitial Lung Disease Therapies: AD-214, Abatacept, ATYR1923, Pirfenidone inhalation, RO-0220912, Lung stem cells, Bardoxolone methyl, Pamrevlumab, Deupirfenidone, INOpulse, OATD 01, LT 0011, GDC 3280,  Blade Therapeutics, BI 1015550, PRA 023, Yifenidone, Riociguat, Treprostinil Palmitil, BMS 986278, Pirfenidone inhalation,  Deupirfenidone, Zinpentraxin alfa, AK 3280, Ianalumab, LTI-03, HZN-825, Tipelukast, ENV-101, PLN-74809, KD025, Setanaxib, TAS-115,Axatilimab, MG-S-2525, GB0139,CSL312 and Saracatinib, others.
  • Interstitial Lung Disease Therapeutic Assessment: Interstitial Lung Disease current marketed and Interstitial Lung Disease emerging therapies
  • Interstitial Lung Disease Market Dynamics: Interstitial Lung Disease market drivers and Interstitial Lung Disease market barriers 

 

Request for Sample PDF Report for Interstitial Lung Disease Pipeline Assessment and clinical trials – Interstitial Lung Disease Clinical Trials and FDA Approvals

 

Table of Contents

1. Interstitial Lung Disease Report Introduction

2. Interstitial Lung Disease Executive Summary

3. Interstitial Lung Disease Overview      

4. Interstitial Lung Disease- Analytical Perspective In-depth Commercial Assessment

5. Interstitial Lung Disease Pipeline Therapeutics

6. Interstitial Lung Disease Late Stage Products (Phase II/III)

7. Interstitial Lung Disease Mid Stage Products (Phase II)

8. Interstitial Lung Disease Early Stage Products (Phase I)

9. Interstitial Lung Disease Preclinical Stage Products

10. Interstitial Lung Disease Therapeutics Assessment

11. Interstitial Lung Disease Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Interstitial Lung Disease Companies

14. Interstitial Lung Disease Key Products

15. Interstitial Lung Disease Unmet Needs

16 . Interstitial Lung Disease Market Drivers and Barriers

17. Interstitial Lung Disease Future Perspectives and Conclusion

18. Interstitial Lung Disease Analyst Views

19. Appendix

20. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Interstitial Lung Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

Bicystar Unveils the Ultimate Adventure Companion for Kids: The BMX 16″ Toddler Bike with Training Wheels

Bicystar, a leading name in children’s adventure gear, proudly announces the launch of its newest creation: the BMX 16” Toddler Bike with Pedals and Training Wheels. Designed for kids aged 3 to 5, this innovative bike combines safety, style, and durability, offering a seamless introduction to the world of cycling.

With birthdays, holidays, and family milestones around the corner, the BMX 16” bike is the perfect way to spark joy and confidence in young riders. Engineered for growing adventurers, this bike is more than just a ride—it’s a gateway to independence and discovery.

Safety remains a top priority for Bicystar. The BMX 16” bike features a robust full chain guard and a reliable coaster brake, ensuring kids can explore freely while parents enjoy peace of mind. Whether on the driveway or park trails, every ride is secure and exciting.

Equipped with a quick-release adjustable seat and handlebars, this bike adapts as your child grows, providing an ergonomic and comfortable riding experience. Sturdy, removable training wheels are perfect for beginners, helping little ones transition from learner to confident cyclist with ease.

The BMX 16” bike isn’t just functional—it’s a head-turner. The sleek black frame, adorned with gleaming shooting star accents, ensures your child stands out in style. This bike reflects the bold spirit of young adventurers, making every ride unforgettable.

Parents rejoice! The bike arrives 85% pre-assembled, with all necessary tools included. Say goodbye to lengthy setup times and hello to more playtime. In just minutes, your child will be ready to hit the pavement.

Bicystar continues its legacy of crafting reliable and stylish products for families. The BMX 16” bike upholds this tradition, offering a durable design that meets the demands of active kids while celebrating their adventurous spirit.

The BMX 16” Toddler Bike with Pedals and Training Wheels is available for purchase on Amazon and Bicystar’s official website and major retailers like Amazon. Priced at $119.99, it offers exceptional value for parents seeking a high-quality bike for their little ones.

About Company:

Bicystar Group Co., Ltd. is a trusted leader in designing bold, family-oriented adventure products, including bikes, strollers, and accessories. With a commitment to safety, style, and innovation, Bicystar empowers young adventurers to explore the world confidently.

Media Contact
Company Name: Bicystar Group Co., Ltd.
Contact Person: Anita B. Parker
Email: Send Email
Country: United States
Website: bicystarstore.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bicystar Unveils the Ultimate Adventure Companion for Kids: The BMX 16″ Toddler Bike with Training Wheels

Bionka Randolph, a Nashville Based Entrepreneur, Launches Humanly to Empower Professionals to Future-Proof their Careers

Humanly helps professionals excel in roles that leverage uniquely human skills like empathy, creativity, and strategic thinking.

The rapidly evolving job market is heavily influenced by automation and artificial intelligence these days. This is where Humanly, a new Nashville-based career platform, aims to empower professionals with skills that technology cannot replicate. Founded by entrepreneur and talent acquisition veteran Bionka Randolph, Humanly is a career development platform designed to prioritize uniquely human abilities such as empathy, creativity, and strategic thinking.

Launched in 2024 and headquartered in Nashville, Tennessee, Humanly focuses on bridging the gap between human potential and technological advancement. The platform provides tools and insights to guide professionals toward roles that are resilient to automation and essential for the future workforce.

After more than 12 years of experience building and leading international teams in fast-paced industries like healthcare, technology, and finance, Randolph recognized an emerging gap in the labor market. While AI and automation continue to streamline repetitive tasks, there remains a growing demand for roles requiring critical thinking and emotional intelligence — skills that technology cannot easily replace.

“Humanly is about creating a future where people and technology work together,” said Randolph. “Our platform is designed to help professionals develop careers that are both meaningful and future-proof.”

Humanly’s mission is to provide data-driven guidance for individuals looking to excel in human-centric roles. The platform aims to not only help people adapt to an evolving job market but also foster a sense of community and resilience among its users. By leveraging advanced tools, Humanly connects users to career opportunities that emphasize human potential while ensuring that professionals are prepared to thrive in industries shaped by technological progress.

The company has already completed its prototype and is actively raising seed capital to build a Minimum Viable Product (MVP) and accelerate its launch.

Randolph’s journey to launching Humanly is rooted in both personal passion and professional experience. As a Black woman entrepreneur, she brings a unique perspective to the technology and workforce development sectors, where representation has historically been limited. Her career in talent acquisition, combined with her hands-on experience solving complex workforce challenges, has positioned her to make a significant impact with Humanly.

“Humanly is more than a platform — it’s a movement to empower people in careers that AI can’t replace,” Randolph said. “We’re creating a future where human skills remain indispensable, and I’m thrilled to make Nashville the base for this vision.”

Randolph sees Nashville as a perfect launchpad for Humanly. The city’s reputation as a center of creativity and innovation aligns closely with the company’s mission. Humanly plans to capitalize on Nashville’s vibrant community to build a robust network of professionals and solidify its place as a leader in workforce resilience.

With plans to roll out its MVP in the coming months, Humanly is gearing up for rapid growth. The company aims to position itself as the go-to platform for professionals seeking to future-proof their careers in a competitive and ever-changing job market.

Users can visit the official website www.humanlynetwork.com, for any media or commercial inquiries or email info@humanlynetwork.com

About Company:

Humanly is a career platform dedicated to empowering individuals in roles that require uniquely human abilities, such as creativity, empathy, and strategic insight. Founded in 2024, the company bridges the gap between human potential and technological advancement to help professionals thrive in a dynamic job market.

Media Contact
Company Name: Humanly
Contact Person: Justin Randolph
Email: Send Email
City: Nashville
State: Tennessee
Country: United States
Website: www.humanlynetwork.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bionka Randolph, a Nashville Based Entrepreneur, Launches Humanly to Empower Professionals to Future-Proof their Careers

Absolute Awakenings: Compassionate and Evidence-Based Addiction Treatment in Denville, New Jersey

“Absolute Awakenings”

Denville, NJ – Substance abuse affects millions of Americans every year, often stemming from underlying factors that require compassionate understanding and targeted care. Absolute Awakenings, a leading drug and alcohol rehab treatment center in Denville, New Jersey, offers a comprehensive approach to recovery that addresses substance use disorders at their core.

Absolute Awakenings emphasizes the transformative power of evidence-based treatments combined with unwavering compassion. The expert team employs advanced technologies and personalized care plans to guide clients on their journey to renewal and strength. By crafting a sanctuary for healing, clients receive the support needed to rediscover hope and rebuild their lives.

What Sets Absolute Awakenings Apart?

– Personalized Treatment Plans: Each client receives an individualized recovery program designed to meet their unique needs and challenges.

– Holistic Care: The approach focuses on healing both the mind and the body, addressing the underlying causes of addiction as well as the physical effects of substance use.

– Supportive Community: Clients become part of a nurturing and understanding community that fosters connection and accountability.

– Serene Environment: The facility provides a peaceful, calming space that promotes relaxation and self-reflection during the recovery process.

“Substance abuse doesn’t define you. Absolute Awakenings embraces each individual with compassion and provides the tools necessary to heal and thrive,” said Spokesperson at Absolute Awakenings. “The mission is to offer not just recovery, but renewal — helping clients rediscover their strength and build a brighter future.”

Absolute Awakenings is dedicated to providing a pathway to recovery that is accessible, effective, and deeply empathetic. By fostering an environment of unconditional care, individuals are empowered to break free from addiction and embrace a healthier, more fulfilling life.

For more information about the New Jersey addiction treatment program or to take the first step towards recovery, please visit https://absoluteawakenings.com/ or call [phone number shared below].

About Absolute Awakenings

Absolute Awakenings is a premier drug and alcohol rehab treatment center located in Denville, New Jersey. The team is committed to helping individuals overcome addiction through innovative therapies, compassionate care, and personalized treatment plans. The facility is dedicated to creating a space where healing and hope thrive.

Media Contact
Company Name: Absolute Awakenings New Jersey Drug & Alcohol Rehab
Contact Person: Admission Office
Email: Send Email
Phone: 9737848981
Address:3000 NJ-10
City: Morris Plains
State: NJ 07950
Country: United States
Website: www.absoluteawakenings.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Absolute Awakenings: Compassionate and Evidence-Based Addiction Treatment in Denville, New Jersey